MassMutual Private Wealth & Trust’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-133	Closed	-$15.4K	–	2143
2023 Q3	$15.4K	Hold	133	–	–	﹤0.01%	866
2023 Q2	$13.7K	Hold	133	–	–	﹤0.01%	862
2023 Q1	$14.5K	Hold	133	–	–	﹤0.01%	816
2022 Q4	$15K	Sell	133 -80	-38%	-$6.64K	﹤0.01%	701
2022 Q3	$13K	Buy	213 +19	+10%	+$1.33K	﹤0.01%	690
2022 Q2	$9K	Buy	194 +66	+52%	+$6.25K	﹤0.01%	755
2022 Q1	$13K	Buy	128 +4	+3%	+$390	﹤0.01%	693
2021 Q4	$13K	Buy	+124	New	+$13.5K	﹤0.01%	688

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

Financial Synergies Wealth Advisors Houston, Texas $1.22B AUM 22.8% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

MassMutual Private Wealth & Trust's HZNP Position: Q4 2023 in Review

MassMutual Private Wealth & Trust sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 133 shares — an estimated $15.4K sold.

MassMutual Private Wealth & Trust first reported a position in HZNP in Q4 2021 and held it in 8 quarters. The position peaked at $15.4K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

MassMutual Private Wealth & Trust reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 133 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $15.4K.
MassMutual Private Wealth & Trust first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 8 quarters.
MassMutual Private Wealth & Trust's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $15.4K in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2023, filed 3 Jan 2024.